V(H)3-21 gene usage in chronic lymphocytic leukemia--characterization of a new subgroup with distinct molecular features and poor survival.
about
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia.Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemiaFCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia.Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions.Restricted, canonical, stereotyped and convergent immunoglobulin responses.Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients.Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition.Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?Cytogenetic testing for therapeutic indication in cancer.Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia.Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohort.Immunoglobulin heavy chain V-D-J gene rearrangement and mutational status in Uruguayan patients with chronic lymphocytic leukemia
P2860
Q33771413-60E5F27C-A9B1-4AB8-B93B-DFB0A21F5D77Q33886052-7B5B4190-0040-446E-827C-3BE05DF1A67DQ34179480-43405850-FEEF-4BDA-B598-BDB32DD44A4AQ36732806-C4C6E18D-633C-43A6-9035-81C4CF77F417Q37971736-D0CA4ED6-F8D1-415C-9592-5F213FA649C2Q38049970-7B3DEC55-F508-4709-8288-3CA9ADD49648Q38551067-843FE8FC-EB76-4C4B-95AE-F8F9D4DDF4ABQ40138593-DF2BA528-67F4-4AB2-9081-06B8101CF5B5Q43186639-B643E1F8-15DB-45EF-900F-24FF34EB02C4Q43518448-BF1F7DC7-278F-4251-901F-9A0EE1016163Q47291002-428121DF-547F-4119-832F-1323FFB98EFDQ53036715-A3D4C134-229F-48AB-B405-832B1B3CDA53Q54387895-D4EDAEB1-E105-459B-96AA-687B91917322Q58484353-5E930445-E9D9-418F-859F-C5E60E0C4B60
P2860
V(H)3-21 gene usage in chronic lymphocytic leukemia--characterization of a new subgroup with distinct molecular features and poor survival.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
V(H)3-21 gene usage in chronic ...... ar features and poor survival.
@ast
V(H)3-21 gene usage in chronic ...... ar features and poor survival.
@en
type
label
V(H)3-21 gene usage in chronic ...... ar features and poor survival.
@ast
V(H)3-21 gene usage in chronic ...... ar features and poor survival.
@en
prefLabel
V(H)3-21 gene usage in chronic ...... ar features and poor survival.
@ast
V(H)3-21 gene usage in chronic ...... ar features and poor survival.
@en
P2093
P2860
P1433
P1476
V(H)3-21 gene usage in chronic ...... ar features and poor survival.
@en
P2093
Gerard Tobin
Richard Rosenquist
Ulf Thunberg
P2860
P304
P356
10.1080/1042819031000147018
P577
2004-02-01T00:00:00Z